South Korea Antimicrobial Susceptibility Testing Market (2024-2029)
The South Korea Antimicrobial Susceptibility Testing Market was valued at $59 Million in 2024 and projected to reach to $76.3 Million by 2029, representing a compound annual growth rate of 5.3%. South Korea's antimicrobial susceptibility testing market is positioned for steady expansion driven by the country's commitment to combating antimicrobial resistance and modernizing diagnostic capabilities.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
South Korea Antimicrobial Susceptibility Testing Market Trends and Insights
- This growth trajectory reflects South Korea's advanced healthcare infrastructure and increasing demand for rapid diagnostic solutions to combat antimicrobial resistance.
- South Korea's investment in laboratory automation and diagnostic innovation positions the country as a key market within the Asia Pacific region. The South Korea market is driven by rising prevalence of infectious diseases, stringent regulatory standards, and healthcare providers' commitment to precision medicine.
- South Korea's pharmaceutical and diagnostic sectors are leveraging cutting-edge technologies to enhance testing accuracy and turnaround times.
- Between 2024 and 2029, South Korea is expected to see accelerated adoption of automated susceptibility testing platforms across hospitals and clinical laboratories. South Korea's competitive landscape includes both domestic and international players offering integrated solutions for microbiology labs.
- South Korea's healthcare system's emphasis on quality control and patient safety continues to fuel demand for reliable antimicrobial susceptibility testing methods..
Key Market Statistics
- CAGR (2024-2029) 5.3% CAGR
- Market Size, 2024 ~USD 59 Million
- Forecast, 2029 ~USD 76.3 Million
- Country South Korea
South Korea Antimicrobial Susceptibility Testing Market Overview
Market Valuation :
South Korea's antimicrobial susceptibility testing market is valued at $59.0 million in 2024, with a projected CAGR of 5.3% through 2029, reaching $76.3 million by forecast end.
Advanced Healthcare Infrastructure :
South Korea's sophisticated healthcare system and high adoption of diagnostic technologies drive demand for rapid and accurate antimicrobial susceptibility testing solutions across clinical laboratories.
Laboratory Automation Investment :
Significant investments in laboratory automation and diagnostic equipment modernization in South Korea are accelerating the adoption of advanced AST platforms and reducing turnaround times for pathogen identification.
Antimicrobial Resistance Focus :
Growing awareness of antimicrobial resistance threats in South Korea is prompting healthcare institutions to implement comprehensive AST programs for improved infection management and antibiotic stewardship.
South Korea Antimicrobial Susceptibility Testing Market Dynamics
- The nation's advanced healthcare infrastructure, coupled with increasing investments in laboratory automation, creates a favorable environment for AST technology adoption among hospitals, diagnostic centers, and research institutions. The forecast period through 2029 will likely see accelerated growth as South Korean healthcare providers prioritize rapid diagnostic solutions to improve patient outcomes and optimize antibiotic therapy.
- Government initiatives supporting diagnostic innovation and infection control protocols will further strengthen market dynamics, positioning South Korea as a key market for antimicrobial susceptibility testing solutions in the Asia-Pacific region..
Related Ecosystem
Healthcare It
- Computed Tomography (CT)
- Machine Learning
- Magnetic Resonance Imaging (MRI)
- Natural Language Processing (NLP)
- Predictive Analytics
- CERNER CORPORATION
- PHILIPS HEALTHCARE
- Oracle Corporation
- GE HealthCare Technologies Inc.
- Siemens healthineers
Medical Devices
- Polymerase Chain Reaction (PCR)
- Magnetic Resonance Imaging (MRI)
- Disposable Autoinjectors
- Pulse Oximeters
- Blood Pressure Monitors
- Medtronic plc
- Abbott Laboratories
- Stryker Corporation
- Becton, Dickinson and Company
- CONMED Corporation
Key Takeaways
- South Korea's antimicrobial susceptibility testing market is valued at $59.0 million in 2024 and will reach $76.3 million by 2029, growing at a 5.3% CAGR.
- South Korea's advanced healthcare infrastructure and regulatory environment drive adoption of automated and rapid testing technologies.
- South Korea's rising antimicrobial resistance concerns and infectious disease prevalence fuel demand for accurate susceptibility testing solutions.
- South Korea's diagnostic sector is increasingly integrating AI and automation to improve laboratory efficiency and clinical outcomes.
Antimicrobial Susceptibility Testing Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2024 |
| Fastest Growing Segment | LAB INSTRUMENTS (Product) |
| Forecast Period | 2024-2029 |
| Growth Rate | CAGR of 5% from 2024 to 2029 |
| Largest Segment | QUALITATIVE METHODS (Method) |
| Market Size Base Year (Billions) | ~USD 4.45 (2024) |
| Revenue Forecast (Billions) | ~USD 5.68 (2029) |
| Segments Covered | Product, Type, Method, Application, End User |
South Korea Antimicrobial Susceptibility Testing Market Report Segmentation
5 segment dimensions are covered across the global market.
By Product
- Consumables
- Lab Disposables
- Lab Instruments
By Type
- Agar Dilution
- Antibacterial Susceptibility Testing
- Antifungal Susceptibility Testing
- Antiparasitic Susceptibility Testing
- Antiviral Susceptibility Testing
- Automated Ast
- Automated Laboratory Instruments
- Broth Macrodilution
- Culture & Growth Media
- Culture And Growth Media
- Disk Diffusion
- Etest Method
- Genotypic Method
- Mic Strips
- Molecular Diagnostics Systems
- Susceptibility Plates
- Susceptibility Testing Disks
By Method
- Qualitative Methods
- Quantitative Methods
By Application
- Clinical Diagnostics
- Drug Discovery & Development
- Epidemiology
- Other Applications
By End User
- Academic & Research Institutes
- Cros
- Hospitals & Diagnostic Centers
- Pharmaceutical & Biotechnology Companies
Target Audience
- In Vitro Diagnostics Manufacturers : IVD companies need South Korea-specific market data to develop localized product strategies, understand competitive positioning, and identify opportunities in the country's growing laboratory automation sector.
- Healthcare System Administrators : Hospital and diagnostic center leaders require market insights to justify AST technology investments, benchmark against South Korean peers, and align procurement decisions with antimicrobial stewardship goals.
- Clinical Laboratory Directors : Laboratory professionals need detailed market analysis to evaluate AST platform options, understand adoption trends among South Korean institutions, and optimize diagnostic workflow efficiency.
- Medical Device Distributors & Suppliers : Distributors operating in South Korea require country-specific market intelligence to identify growth opportunities, assess demand from healthcare facilities, and develop targeted sales strategies.
- Healthcare Investment & Consulting Firms : Investment professionals and consultants need comprehensive South Korea market data to evaluate portfolio opportunities, assess market attractiveness, and support strategic decision-making in the diagnostics sector.
Reasons to Buy this Report
- Market-Specific Growth Insights : Gain detailed understanding of South Korea's 5.3% CAGR trajectory and identify high-growth segments within the country's $59.0M to $76.3M market expansion through 2029.
- Competitive Landscape Analysis : Understand South Korean market dynamics, key players, and competitive positioning specific to the country's advanced healthcare infrastructure and diagnostic technology adoption patterns.
- Investment & Expansion Strategy : Develop targeted market entry or expansion strategies for South Korea by leveraging country-specific data on laboratory automation investments, healthcare spending, and antimicrobial resistance initiatives.
- Regulatory & Healthcare Environment : Access insights into South Korea's healthcare regulations, reimbursement policies, and diagnostic standards that directly impact AST market opportunities and product commercialization strategies.
- Customer Segmentation & Demand Drivers : Identify and prioritize key customer segments in South Korea including hospitals, diagnostic centers, and research institutions, with clear understanding of their specific AST testing needs and adoption drivers.
Frequently asked questions
What is the current market size of antimicrobial susceptibility testing in South Korea?
South Korea's antimicrobial susceptibility testing market was valued at $59.0 million in 2024 and is expected to grow to $76.3 million by 2029.
What is the projected growth rate for South Korea's antimicrobial susceptibility testing market?
South Korea's market is projected to grow at a compound annual growth rate (CAGR) of 5.3% from 2024 to 2029.
What factors are driving growth in South Korea's antimicrobial susceptibility testing market?
South Korea's market growth is driven by rising antimicrobial resistance, advanced healthcare infrastructure, stringent regulatory standards, and increasing adoption of automated diagnostic technologies.
Which technologies are most commonly used in South Korea's antimicrobial susceptibility testing?
South Korea's laboratories increasingly utilize automated platforms, rapid molecular testing methods, and AI-integrated systems to enhance testing accuracy and reduce turnaround times.
How does South Korea's market compare to other Asia Pacific countries?
South Korea's advanced healthcare system, high diagnostic adoption rates, and strong regulatory framework position it as a leading market within the Asia Pacific region for antimicrobial susceptibility testing.
RESEARCH METHODOLOGY
In that respect, the research has heavily employed both primary and secondary sources in order to comprehensively study the forces influential in the industry. This methodology comprised market segmentation analysis, industry trends, major players, competitive landscape, key market dynamics, and strategies of key companies.
Secondary Research
The secondary research involves D&B Hoovers, Bloomberg Businessweek, Factiva, white papers, annual reports, company filings, investor presentations, and SEC filings for conducting secondary research in developing a database on major industry participants. Key data with regard to leading players, market segmentation, at a various level, industry trends by segments, significant mergers and acquisitions, and the impact of trends and technological perspectives related to the antimicrobial susceptibility testing market.
Primary Research
Primary research in the report included interviewing a cross-section, both from the demand and supply sides, to capture information qualitatively and quantitatively. Supply side: High-level executives' interviews, such as CEOs, VPs, marketing and sales directors, regional sales managers, and technology and innovation directors were contacted from leading companies and organizations in product therapy markets. On the demand side, research was carried out by discussing with professionals like clinicians, procurement managers, purchase managers, department heads, and experts from hospitals, diagnostic centers, pharmaceutical and biotechnological firms, and research and academic institutes. This was necessary to gain a proper view of the market segmentation, significant players in the market, and key trends and dynamics related to the growth of the market.
A breakdown of the primary respondents is provided below:
*Others include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.
Note: Companies are classified into tiers based on their total revenue. As of 2023, Tier 1 = >USD 1 billion, Tier 2 = < USD 500 million, and Tier 3 = < USD 100 million.
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
This research examines the Antimicrobial Susceptibility testing market and revenue share among the market leaders. It made use of a combination of primary and secondary research methods to do so. Primary research involved in-depth interviews with CEOs, directors, and senior marketing executives. Secondary research formed annual and financial reports by major industry players. The market value was determined while following a segment-based strategy, and it used revenue details of leading solution providers for differentiating between sources and services.
Covered segments:
Identify the major companies involved in the world Antimicrobial Susceptibility testing market and document their annual revenues or revenues from their particular product category/business division.
The revenue mapping of these leading competitors, based on 2024 data, captures a good share of the market and is thus extrapolated to estimate the total global value of the Antimicrobial Susceptibility testing market:
Data Triangulation
Based on the methodology, categorical and sub-categories segmentation of the global antimicrobial susceptibility testing market was performed. Further, data triangulation and the segmentation process were undertaken to arrive at an accurate data of different segments for the market. Various analyses involved factors and trends of the demand and supply sides. The integration of detailed top-down and bottom-up approaches offered a holistic overview of the antimicrobial susceptibility testing market
Market Definition
The Antimicrobial Susceptibility Testing market involves the diagnosis and determination of effectiveness against pathogens such as bacteria, fungi, and viruses using antimicrobial agents. It consists of several technologies and methodologies employed for the diagnosis of the susceptibility of microorganisms to a variety of antimicrobial agents through automated systems, molecular diagnostics, and traditional culture-based methods. The main aim of AST is to be able to choose appropriate therapy, enhance patient outcomes, and take against the threat of emerging antimicrobial resistance. The market includes products and services used by clinical laboratories, hospitals, research institutions, and other healthcare facilities.
Stakeholders
- Healthcare institutions (hospitals and clinics)
- Healthcare institutions (hospitals and diagnostic centers)
- Research institutions
- Clinical research organizations
- Academic medical centers and universities
- Reference laboratories
- Accountable Care Organizations (ACOs)
- Research and consulting firms
- Contract research organizations (CROs) and contract manufacturing organizations (CMOs)
- Academic medical centers and universities
- Market research and consulting firms
- Group Purchasing Organizations (GPOs)
- Medical Research Laboratories
- Academic Medical Centers and Universities
Report Objectives
- Define, describe, and project the antimicrobial susceptibility testing (AST) market across various dimensions, including product, type, methods, applications, end users, and regional areas.
- Explore opportunities for stakeholders and provide a detailed analysis of the competitive landscape, highlighting the key players in the market.
- Offer comprehensive insights into the principal factors influencing market growth.
- Analyze micro markets by evaluating individual growth trends, potential, and their contributions to the overall market.
- Monitor and review competitive developments such as new product launches, approvals, agreements, partnerships, expansions, acquisitions, and collaborations in the AST sector.
Get the Full Antimicrobial Susceptibility Testing Market Report
Full forecast, segment splits, and company analysis for all Antimicrobial Susceptibility Testing Market.
- Canada Antimicrobial Susceptibility Testing Market
- US Antimicrobial Susceptibility Testing Market
- Germany Antimicrobial Susceptibility Testing Market
- France Antimicrobial Susceptibility Testing Market
- UK Antimicrobial Susceptibility Testing Market
- Italy Antimicrobial Susceptibility Testing Market
- Spain Antimicrobial Susceptibility Testing Market
- Japan Antimicrobial Susceptibility Testing Market
- China Antimicrobial Susceptibility Testing Market
- India Antimicrobial Susceptibility Testing Market
- Australia Antimicrobial Susceptibility Testing Market
- Brazil Antimicrobial Susceptibility Testing Market
- Mexico Antimicrobial Susceptibility Testing Market
- Rest Of Europe Antimicrobial Susceptibility Testing Market
- Rest Of Asia Pacific Antimicrobial Susceptibility Testing Market
- Rest Of Latin America Antimicrobial Susceptibility Testing Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report
